AzTrials
AzTrials

Older Adults (65 Years and Older)RECAPNCT07680036

RESISTANCE TRAINING AND CAPILLARIZATION - ROLE ON THE ANABOLIC RESPONSE IN OLDER ADULTS

A study testing Exercise in people with Older Adults (65 Years and Older), run by University of Padova at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn how muscle capillaries influence the response to resistance exercise training in older adults. The study will include older men and women who may experience age-related declines in muscle mass and function. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Older Adults (65 Years and Older)
What is being tested?
Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteItaly
Study dates
1 Jan 2024to 31 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Age ≥ 65 years
  • Body Mass Index (BMI) >18 and <30 kg/m²
  • Stable body weight for at least 3 months prior to enrollment

Who cannot join

  • Prediabetes or diabetes according to ADA criteria
  • Chronic diseases, including cardiovascular, liver, respiratory diseases, or cancer
  • Acute inflammatory conditions, infections, or other clinically significant illnesses
  • Regular participation in vigorous physical activity (≥2 sessions per week)
  • Current or recent (within the previous 3 months) treatment with steroid medications
  • Regular use of protein supplements

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Nutrition and Exercise Lab, DSB

    Padova, PD, 35131

Other trials in Italy

About this study

The goal of this clinical trial is to learn how muscle capillaries influence the response to resistance exercise training in older adults. The study will include older men and women who may experience age-related declines in muscle mass and function. The main questions it aims to answer are:

  • Does baseline muscle capillarization influence the increase in muscle size and function following resistance exercise training?
  • Can resistance exercise stimulate the formation of new capillaries in older adults with lower baseline capillarization, and how is this related to muscle growth?
Read more

Participants will:

  • Undergo assessments of muscle structure, capillarization, and physical function before and after the intervention.
  • Participate in a supervised resistance exercise training program.
  • Provide muscle samples and other physiological measurements to evaluate changes in muscle growth and blood vessel formation.

Researchers will analyze the relationship between baseline muscle capillarization, exercise-induced angiogenesis, and improvements in muscle mass and function to better understand why some older adults respond more effectively to resistance exercise than others.

Read the detailed description

This randomized clinical trial will investigate the effects of different exercise training strategies on skeletal muscle adaptations in older adults. Participants will be randomly assigned to one of three training groups and will complete a supervised 12-week exercise program, consisting of three sessions per week.

The interventions will include different combinations and sequencing of resistance and aerobic exercise during the first 8 weeks of training, followed by a standardized resistance training program during the final 4 weeks. The study is designed to determine whether the timing and type of exercise influence muscle growth, vascular adaptations, and functional outcomes.

Participants will undergo assessments before the intervention and after 4, 8, and 12 weeks of training. Measurements will include body composition, muscle size and architecture, muscle strength, aerobic fitness, and physical function. A subgroup of participants may also undergo optional muscle biopsies to evaluate changes in muscle capillarization and biological markers associated with muscle adaptation.

The results will help identify exercise strategies that optimize muscle and vascular adaptations in older adults and improve understanding of the mechanisms underlying individual variability in training responsiveness.

Being tested
Exercise
Keywords
resistance training, capillary density, muscle hypertrophy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseOther

    2 months of different combination of aerobic and resistance training before undergoing to 1 month of resistance training at 80% 1RM

Study groups in NCT07680036
Study groupRoleWhat they receive
RRRActive comparatorEffect of 3 months of progressive resistance training on muscle adaptation in older adults
Receives: Other: Exercise
ARRActive comparatorEffect of 1 month of aerobic training followed by 2 months of progressive resistance training on muscle adaptation in older adults
Receives: Other: Exercise
RARActive comparatorEffect of the combination of 1 month of resistance training followed by 1 month of aerobic training and 1 months of progressive resistance training on muscle adaptation in older adults
Receives: Other: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. muscle hypertrophy

    difference of kilograms of Lean Body Mass from baseline measured by DEXA

    Measured: 3 months

  2. capillary density

    change on the number of capillary per muscle fiber measured histochemically trought muscle biopsy.

    Measured: 3 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2026
  2. Study start1 Jan 2024
  3. Primary completion31 Dec 2025
  4. Study completion31 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07680036
Sponsor's protocol ID
RECAP
Acronym
RECAP
Status last verified
Jan 2024
First submitted
25 Jun 2026
Last updated
7 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise in people with Older Adults (65 Years and Older), run by University of Padova at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

muscle hypertrophy (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in